ACET (Adicet Bio, Inc.) Stock Market Reviews

crown

search

Read and share opinions on ACET (Adicet Bio, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

ACET

Adicet Bio, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
Nov 5, 2025
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Oct 31, 2025
Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference
Oct 28, 2025
Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA)
Oct 16, 2025
Are Medical Stocks Lagging Exact Sciences (EXAS) This Year?
Oct 7, 2025
Adicet Bio, Inc. Announces $80 Million Registered Direct Offering
Oct 7, 2025
Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)
Oct 7, 2025
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Sep 30, 2025
Adicet Bio (ACET) Upgraded to Buy: Here's What You Should Know
Sep 30, 2025
Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Sep 2, 2025
Adicet Bio (ACET) Upgraded to Buy: Here's Why
Aug 12, 2025
Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
Aug 7, 2025
Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference
Aug 5, 2025
Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
Jul 24, 2025
Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference
May 21, 2025

Reviews